Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has provided an announcement.
Asymchem Laboratories (Tianjin) Co., Ltd. has announced that its board of directors will convene on 30 October 2025 to review and approve the company’s third quarterly results for the period ending 30 September 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholder decisions and market positioning.
The most recent analyst rating on (HK:6821) stock is a Buy with a HK$123.00 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on providing comprehensive services in drug development and manufacturing, catering to a global market.
Average Trading Volume: 917,005
Technical Sentiment Signal: Buy
Current Market Cap: HK$39.31B
For a thorough assessment of 6821 stock, go to TipRanks’ Stock Analysis page.